The lack of PALB2 methylation-positive samples in our study might be explained by the fact that we have investigated high-grade serous ovarian cancer cases only, which presumably evolve via a different tumorigenic pathway of development than clear cell carcinomas[20]. The gene discussed is PALB2; the disease is ovarian serous adenocarcinoma.